Xilio Therapeutics Inc. (XLO) NASDAQ

$2.46 -0.06 (-2.38%)

Market Cap: $67.58M

As of 08/12/22 04:30 PM EDT. Market closed.

(XLO)

Xilio Therapeutics Inc. (XLO) NASDAQ

$2.46 -0.06 (-2.38%)

Market Cap: $67.58M

As of 08/12/22 04:30 PM EDT. Market closed.

Xilio Therapeutics is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. The company is using its proprietary geographically precise solutions (GPS) platform to rapidly engineer novel molecules, including cytokines and other biologics, that are designed to optimize their therapeutic index. ... read more

Xilio Therapeutics is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. The company is using its proprietary geographically precise solutions (GPS) platform to rapidly engineer novel molecules, including cytokines and other biologics, that are designed to optimize their therapeutic index. These molecules are designed to localize activity within the tumor microenvironment without systemic effect, resulting in the potential to achieve enhanced anti-tumor activity. Xilio is building a pipeline of wholly-owned, tumor-selective, GPS-enabled cytokine and checkpoint inhibitor product candidates, including XTX101, a tumor-selective anti-CTLA-4 monoclonal antibody; XTX202, a tumor-selective IL-2; XTX301, a tumor-selective IL-12; and XTX401, a tumor-selective IL-15. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
2,021
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$2.52
Days Range
$2.46 - $2.54
52 week range
$2.04 - $27.95
Volume
336,608
Avg. Volume (30 days)
87,568
Market Cap
$67.58M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
27,471,607
Open
$0
Previous Close
$2.52
Days Range
$2.46 - $2.54
52 week range
$2.04 - $27.95
Volume
336,608
Avg. Volume (30 days)
87,568
Market Cap
$67.58M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
27,471,607

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR XILIO THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Bain Capital Life Sciences Investors, LLC 10% Owner Dec 08, 2021 Buy $9.62 13,458 129,474 2,776,402 Dec 10, 2021, 08:33 PM
Bain Capital Life Sciences Investors, LLC 10% Owner Dec 10, 2021 Buy $9.65 25,000 241,202 2,805,413 Dec 10, 2021, 08:33 PM
Bain Capital Life Sciences Investors, LLC 10% Owner Dec 09, 2021 Buy $9.84 4,011 39,485 2,780,413 Dec 10, 2021, 08:33 PM
SV7 Impact Medicine Fund LP 10% Owner Oct 26, 2021 Buy $16.00 312,500 5,000,000 1,613,632 Nov 03, 2021, 04:20 PM
SV7 Impact Medicine Fund LP 10% Owner Oct 26, 2021 Buy $16.00 312,500 5,000,000 1,613,632 Nov 03, 2021, 04:20 PM
Flynn James E 10% Owner Oct 26, 2021 Buy $16.00 387,500 6,200,000 1,143,972 Oct 28, 2021, 07:15 PM
Flynn James E 10% Owner Oct 26, 2021 Buy $16.00 387,500 6,200,000 1,143,972 Oct 28, 2021, 07:15 PM
RiverVest Venture Fund IV, L.P. 10% Owner Oct 26, 2021 Buy $16.00 250,000 4,000,000 1,441,444 Oct 26, 2021, 05:30 PM
Rock Springs Capital Management LP 10% Owner Oct 26, 2021 Buy $16.00 500,000 8,000,000 1,256,472 Oct 26, 2021, 05:04 PM
BAY CITY CAPITAL LLC 10% Owner Oct 26, 2021 Buy $16.00 312,500 5,000,000 1,129,490 Oct 26, 2021, 05:02 PM
Atlas Venture Fund XI, L.P. 10% Owner Oct 26, 2021 Buy $16.00 187,500 3,000,000 735,942 Oct 26, 2021, 05:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Bain Capital Life Sciences Investors, LLC 10% Owner 12/08/2021 129,474
Bain Capital Life Sciences Investors, LLC 10% Owner 12/10/2021 241,202
Bain Capital Life Sciences Investors, LLC 10% Owner 12/09/2021 39,485
SV7 Impact Medicine Fund LP 10% Owner 10/26/2021 5,000,000
SV7 Impact Medicine Fund LP 10% Owner 10/26/2021 5,000,000
Flynn James E 10% Owner 10/26/2021 6,200,000
Flynn James E 10% Owner 10/26/2021 6,200,000
RiverVest Venture Fund IV, L.P. 10% Owner 10/26/2021 4,000,000
Rock Springs Capital Management LP 10% Owner 10/26/2021 8,000,000
BAY CITY CAPITAL LLC 10% Owner 10/26/2021 5,000,000
Atlas Venture Fund XI, L.P. 10% Owner 10/26/2021 3,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
03/31/2022
0.03%
1Q

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2022
0.03%
1Q